Search results for " parkin"

showing 10 items of 122 documents

Is Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound a Repeatable Treatment Option? Case Report of a Retreated Patient With Tremor Co…

2019

Introduction In recent years, transcranial Magnetic Resonance Imaging-guided Focused Ultrasound (tcMRgFUS) treatments for functional neurological disorders are giving a new thrust to the field of therapeutic brain lesioning. Objective To present the case of a patient affected by tremor combined with Parkinsonism who underwent a second tcMRgFUS thalamotomy because of relapsing tremor after a few months from the first tcMRgFUS treatment. Methods A 72-yr-old, right-handed man, came to our observation because of a disabling tremor affecting his upper limbs, refusing any invasive surgical procedure and already treated by tcMRgFUS left Vim thalamotomy. However, clinical benefit had brief duration…

Malemedicine.medical_specialtyInterventional magnetic resonance imagingmedicine.medical_treatmentEssential TremorFocused ultrasoundParkinsonian DisordersTremorMedicineHumansAgedmedicine.diagnostic_testbusiness.industryPatient affectedThalamotomySettore MED/27 - NeurochirurgiaParkinsonismSettore FIS/01 - Fisica SperimentaleTreatment optionsSettore MED/37 - NeuroradiologiaMagnetic resonance imagingmedicine.diseaseMagnetic Resonance ImagingTreatment OutcomeStereotaxic techniqueSurgerySettore MED/26 - NeurologiaNeurology (clinical)RadiologyHigh-intensity focused ultrasound ablation Minimally invasive surgical procedures Stereo- taxic techniques Tremor Parkinsonian disorders Interventional magnetic resonance imaging Intraoperative monitoringbusinessSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Effects of progressive resistance exercise in akinetic-rigid Parkinson's disease patients: a randomized controlled trial.

2017

Progressive resistance exercise (PRE) can have a positive effect in individuals with Parkinson’s disease (PD). However, the effect of PRE may vary with the clinical subtype of PD. To date, no study has assessed the effects of PRE in the different subtypes of PD. AIM: The aim of the present study was to assess the effects of PRE in PD patients with akinesia and rigidity (AR-subtype). DESIGN: A randomized controlled trial was conducted. SETTING: Outpatients clinics of the Bierzo Parkinson Association (Ponferrada, Spain) and the Asturias Parkinson Association (Oviedo, Spain). POPULATION: Twenty-eight patients with AR-subtype PD were randomized into an Experimental Group (EG, N.=13) and Control…

Malemedicine.medical_specialtyMovement disordersParkinson's diseasemedicine.medical_treatmentCondición física - EjerciciosPopulationEnfermedad del sistema nerviosoPhysical Therapy Sports Therapy and RehabilitationRisk Assessmentlaw.invention03 medical and health sciencesTratamiento médico0302 clinical medicineRhythmPhysical medicine and rehabilitationRandomized controlled triallawRating scaleReference ValuesMedicineHumans030212 general & internal medicineeducationGaitPostural BalanceAgededucation.field_of_studyRehabilitationbusiness.industryRehabilitationPosturographyParkinson DiseaseResistance TrainingDeporteMiddle Agedmedicine.diseaseExercise TherapyTreatment OutcomeEnfermedad de ParkinsonSpainPhysical therapyParkinson’s diseaseFemalemedicine.symptombusiness030217 neurology & neurosurgeryFollow-Up StudiesEuropean journal of physical and rehabilitation medicine
researchProduct

Non-occlusive mesenteric Ischemia (NOMI) in Parkinson’s disease: Case report

2017

Non-occlusive mesenteric ischemia (NOMI) is a severe pathological condition characterized by signs and symptoms of bowel obstruction, intestinal necrosis resulting from acute and/or chronic inadequate blood perfusion, in the absence of an organic vascular obstruction detectable by imaging techniques. A 64 years old man case with a history of Parkinson’s disease in high-functioning levodopa treatment is presented. Clinical and radiological signs of intestinal obstruction were observed. He underwent surgical operation with total colectomy and terminal ileostomy for generalized secondary peritonitis due to perforation of sigmoid colon. Ischemic pancolitis was first suspected. In third post-o…

Malemedicine.medical_specialtyPancolitisNon-occlusive mesenteric ischemia (NOMI)medicine.medical_treatmentPerforation (oil well)Intestinal necrosiurologic and male genital diseasesGastroenterologyTotal colectomyClinical PracticeIleostomymedicine.arteryInternal medicineVasodilatormedicineHumansParkinson’s diseaseSuperior mesenteric arteryVeinBowel obstruction; Intestinal necrosis; Non-occlusive mesenteric ischemia (NOMI); Parkinson’s disease; Total colectomy; Vasodilators; Surgerybusiness.industrySigmoid colonParkinson DiseaseMiddle Agedmedicine.diseaseSurgeryBowel obstructionSettore MED/18 - Chirurgia Generalemedicine.anatomical_structureMesenteric ischemiaMesenteric IschemiaSurgerymedicine.symptombusinessTomography X-Ray ComputedIntestinal ObstructionBowel obstruction
researchProduct

Ambulante Therapie & Telemonitoring von Patienten mit Parkinson

2011

Körpernahe Sensornetzwerke können schon heute zur Steigerung der Lebensqualität beitragen, indem der Patient sein gewohntes Umfeld nicht zwingend verlassen muss. Der natürliche und nächste Schritt zur Verbesserung dieser wertvollen Diagnosesysteme beruht auf die Einbeziehung körpernaher Aktuatoren, welche auch eine gleichzeitige Therapierung erlauben. Durch einen interdisziplinären Ansatz, der klinische und technologische Erkenntnisse vereint, entsteht ein Sen-sor- und Aktuatornetzwerk, das am Beispiel eines sich in Entwicklung befindlichen innovativen Systems zur Behandlung von Parkinson vorgestellt wird.

Morbus ParkinsonIntelliDrugSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoSensornetzwerke
researchProduct

Nitric oxide: Implications for the etiology & treatment of central nervous system disorders

2011

Nitric oxide basal ganglia Parkinson's diseaseSettore BIO/09 - Fisiologia
researchProduct

Surgery of Parkinson's disease. Experience in Messina

2003

No abstract

Parkinson disease DBSParkinson disease DBS movement disordersItalyElectric Stimulation Therapy; Humans; Italy; Neurosurgical Procedures; Parkinson DiseaseSettore MED/27 - NeurochirurgiaHumansElectric Stimulation TherapyParkinson DiseaseNeurosurgical Procedures
researchProduct

E163L HOMOZYGOUS DJ-1 MUTATION IN A FAMILY FROM SOUTHERN ITALY WITH AMIOTROPHIC LATERAL SCLEROSIS-PARKINSONISM-DEMENTIA COMPLEX.

2004

Parkinson disease mutation genetic parkinsonism
researchProduct

Effects of mutations of wild-type alpha-synuclein on its structure and dimerization and consequences for the Parkinson's disease : answers from coars…

2022

Alpha-synuclein is a protein of 140 amino acids, intrinsically disordered and found abundantly in the brain and whose toxic aggregation there is the hallmark of the Parkinson's disease.The aim of the thesis is to understand the effects of certain mutations on the dimerization of alpha-synuclein and to contribute to understand its involvement in Parkinson's disease by using coarse-grained molecular dynamics. Coarse-grained molecular dynamics trajectories were computed using the UNited-RESidue (UNRES) program and provided unprecedented sampling (over an effective time of the order of milliseconds) of the alpha-synuclein structures in monomeric and dimeric forms. These data were generated both…

Parkinson diseaseAlpha-Synucléine[CHIM.MATE] Chemical Sciences/Material chemistryAlpha-SynucleinMaladie de ParkinsonDynamique moléculaire[PHYS.PHYS] Physics [physics]/Physics [physics]Molecular dynamics
researchProduct

Commentary: Anderson‐Fabry Disease: A Rare Cause of Levodopa‐Responsive Early Onset Parkinsonism

2021

NA

Pediatricsmedicine.medical_specialtyLevodopaAnderson-Fabry DiseaseNeurologybusiness.industrymedicineAnderson-Fabry disease early onset parkinsonism levodopa response lysosomal storage diseasesNeurology (clinical)Early onset parkinsonismbusinessCase Reports and Commentariesmedicine.drugMovement Disorders Clinical Practice
researchProduct

Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale

2020

Neurodegenerative diseases such as Alzheimer&rsquo

Proteomicsamyotrophic lateral sclerosisParkinson's diseaseDatabases FactualProteomeDiseaseComputational biologyBiologyPolymorphism Single NucleotideArticleTranscriptomeImmune systemHuntington's diseaseAlzheimer DiseasemedicineHumansbiochemistryAmyotrophic lateral sclerosislcsh:QH301-705.5GeneAlzheimer’s disease ; multi-omics ; neurodegeneration ; Huntington’s disease ; Parkinson’s disease ; amyotrophic lateral sclerosisNeurodegenerationneurodegenerationNeurodegenerative DiseasesParkinson DiseaseGenomicsGeneral Medicinemulti-omicsmedicine.diseaseImmunity HumoralGene OntologyHuntington Diseaselcsh:Biology (General)Parkinson’s diseaseTranscriptomeAlzheimer’s diseaseGenome-Wide Association StudyHuntington’s disease
researchProduct